Semaglutide biosimilar(Lepu Pharmaceutical)
司美格鲁肽生物类似药（乐普药业）
Report date: 2025/10/29 17:32:51
Base Information
Drug NameSemaglutide biosimilar(Lepu Pharmaceutical)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesLepu Pharmaceutical Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesLepu Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A